Exchange Traded Concepts’s Veradermics MANE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.66M Buy
30,224
+56
+0.2% +$6.12K 0.01% 586
2026
Q2
$3.71M Buy
+30,168
New +$2.83M 0.02% 549

Other funds holding MANE

Exchange Traded Concepts's MANE Position: Q3 2026 in Review

Exchange Traded Concepts increased its Veradermics (MANE) stake by 0.19% in Q3 2026, buying an estimated $6.12K and bringing the position to 30,224 shares worth $3.66M. The position accounts for 0.01% of the portfolio, ranked #586.

Exchange Traded Concepts first reported a position in MANE in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.71M in Q2 2026. 206 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • Exchange Traded Concepts held 30,224 shares of Veradermics worth $3.66M as of Q3 2026.
  • Exchange Traded Concepts bought 56 Veradermics shares in Q3 2026, an estimated $6.12K.
  • Veradermics made up 0.01% of Exchange Traded Concepts's portfolio in Q3 2026, its #586 holding.
  • Exchange Traded Concepts first reported a position in Veradermics in Q2 2026 and has held it in 2 quarters since.
  • Exchange Traded Concepts's Veradermics position peaked at $3.71M in Q2 2026.
  • 206 funds tracked by Wall St. Rank held Veradermics as of Q3 2026.

Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.